Journal article
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
- Abstract:
-
Objective: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets.
Methods: We performed an open-label pilot study with three phases of 2 months each (baseline, treatment and withdrawal) in eight patients with GL...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- BMJ Publishing Group Publisher's website
- Journal:
- Journal of Neurology, Neurosurgery and Psychiatry Journal website
- Volume:
- 87
- Issue:
- 5
- Pages:
- 550-553
- Publication date:
- 2015-11-03
- Acceptance date:
- 2015-10-14
- DOI:
- EISSN:
-
1468-330X
- ISSN:
-
0022-3050
- Pmid:
-
26536893
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
1092905
- Local pid:
- pubs:1092905
- Deposit date:
- 2020-03-12
Terms of use
- Copyright holder:
- Mochel et al.
- Copyright date:
- 2016
- Rights statement:
- Copyright © The Author(s) 2015. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
- Licence:
- CC Attribution-NonCommercial (CC BY-NC)
If you are the owner of this record, you can report an update to it here: Report update to this record